-
881por Ivanyi-Nagy, Roland, Kanevsky, Igor, Gabus, Caroline, Lavergne, Jean-Pierre, Ficheux, Damien, Penin, François, Fossé, Philippe, Darlix, Jean-Luc“…The core protein of hepatitis C virus (HCV) has been shown previously to act as a potent nucleic acid chaperone in vitro, promoting the dimerization of the 3′-untranslated region (3′-UTR) of the HCV genomic RNA, a process probably mediated by a small, highly conserved palindromic RNA motif, named DLS (dimer linkage sequence) [G. …”
Publicado 2006
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
882“…BACKGROUND: Hepatitis C Virus (HCV) is a significant public health burden and small animal models are needed to study the pathology and immunobiology of the virus. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
883“…Hepatitis C Viral (HCV) infection in the injection drug user (IDU) population is a major medical concern. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
884
-
885“…BACKGROUND: We describe the first case of systemic cat scratch disease in a patient receiving peginterferon α-2a and ribavirin for treatment of hepatitis C. Cases of adult systemic CSD are extremely infrequent and immunomodulatory treatment for hepatitis C has been associated with aberrant host responses to common pathogens. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
886por Elsheikh, Rasha M, Daak, Ahmed A, Elsheikh, Mohamed A, Karsany, Mubarak S, Adam, Ishag“…AIM: The study aimed to investigate the sero-prevalance and the possible risk factors for hepatitis B virus (HBV) and hepatitis C virus (HCV) among antenatal care attendants in central Sudan. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
887por Lechner, Franziska, Wong, David K.H., Dunbar, P. Rod, Chapman, Roger, Chung, Raymond T., Dohrenwend, Paul, Robbins, Gregory, Phillips, Rodney, Klenerman, Paul, Walker, Bruce D.“…Although hepatitis C virus (HCV) infection is very common, identification of patients during acute infection is rare. …”
Publicado 2000
Enlace del recurso
Enlace del recurso
Texto -
888“…We report the case of a 60-year-old man with mild Christmas disease, Factor IX 10% of normal, who developed chronic hepatitis C infection after receiving coagulation factor concentrates. …”
Enlace del recurso
Enlace del recurso
Texto -
889por Henke, Jura Inga, Goergen, Dagmar, Zheng, Junfeng, Song, Yutong, Schüttler, Christian G, Fehr, Carmen, Jünemann, Christiane, Niepmann, Michael“…Hepatitis C virus (HCV) is a positive strand RNA virus that propagates primarily in the liver. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
890“…Six cases of acute hepatitis C related to computed tomography scanning with contrast were identified in 3 hospitals. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
891por Siddiqui, Firdous A., Ehrinpreis, Murray N., Janisse, James, Dhar, Ravi, May, Elizabeth, Mutchnick, Milton G.“…PURPOSE: Recent studies suggest that African Americans (AA) with chronic hepatitis C (CHC) differ from non-Hispanic whites (NHW) with respect to the natural history and mortality resulting from the complications of chronic liver disease. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
892“…A significant proportion of patients with chronic hepatitis C virus (HCV) infection who undergo antiviral therapy have persistent or recurrent viremia and fail to achieve a sustained virologic response (SVR). …”
Enlace del recurso
Enlace del recurso
Texto -
893por Sabahi, Ali“…Approximately 170 million are infected with the hepatitis C virus (HCV) world wide and an estimated 2.7 million are HCV RNA positive in the United States alone. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
894por Matsuoka, Shunichi, Matsumura, Hiroshi, Nakamura, Hitomi, Oshiro, Shu, Arakawa, Yasuo, Hayashi, Junpei, Sekine, Naoki, Nirei, Kazushige, Yamagami, Hiroaki, Ogawa, Masahiro, Nakajima, Noriko, Amaki, Shuichi, Tanaka, Naohide, Moriyama, MitsuhikoEnlace del recurso
Publicado 2009
Enlace del recurso
Enlace del recurso
Texto -
895“…The precipitation can remove the hepatitis C virus and the antibody of cryoglobulins from serum leading to a false negative result. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
896
-
897por Poggi, Guido, Villani, Laura, Sottotetti, Federico, Tagliaferri, Barbara, Montagna, Benedetta, Amatu, Alessio, Bernardo, Giovanni“…The currently recommended treatment for patients infected with hepatitis C virus (HCV) is pegilated interferon α (IFN α) plus ribavirin. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
898
-
899por Tinè, Fabio“…BACKGROUND AND AIM: Antiviral therapy with peg-interferon and ribavirin induces sustained virus eradication in 40%–80% of patients with chronic hepatitis C virus (HCV). We investigated patient views on their involvement in therapeutic decision making and on the desirability of disease and treatment-related outcomes. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Texto -
900“…BACKGROUND: Hepatitis C virus (HCV) is a blood-borne flavivirus that infects many millions of people worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto